EUCTR2006-003053-24-ITActive, not recruitingNot Applicable
Prophylaxis with fenoldopam in cardiac surgery patients at high risk of postoperative renal failure - ND
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 sites160 target enrollmentStarted: December 14, 2006Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 160
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •cardiac surgery requiring cardiopulmonary bypass in patients - high risk of postoperative renal failure - informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •-preoperative dialysis, - glaucoma, - allergy to fenoldopam
Investigators
Similar Trials
Completed
Phase 3
Fenoldopam and Acute Renal FailureAcute Renal FailureNCT00621790Università Vita-Salute San Raffaele667
Completed
Phase 4
Fenoldopam and Splanchnic Perfusion During Cardiopulmonary BypassCardiac ComplicationsCardiopulmonary BypassNCT00747331IRCCS Policlinico S. Donato80
Completed
Phase 3
Fenoldopam in Pediatric Cardiac SurgeryKidney Failure, AcuteNCT00982527Bambino Gesù Hospital and Research Institute80
Active, not recruiting
Not Applicable
Sevoflurane on cardiac surgery: vantage to use during CECgeneral anestetic inalathory also during CECMedDRA version: 6.1Level: PTClassification code 10018060EUCTR2005-001574-27-ITAZIENDA OSPEDALIERA DI PERUGIA
Completed
Phase 2
To study the role of febuxostat in decreasing adverse effects of free radicals in cardiac surgeryCTRI/2021/01/030807AIIMS60